Pharmacokinetics of Faldaprevir of Soft Capsule

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Healthy
Interventions
DRUG

faldaprevir(high dose)

faldaprevir(high dose) will be taken by 1 day single use and 10 days multiple use. the subjects will be assigned to high dose treatment in random order

DRUG

Faldaprevir(low dose)

faldaprevir(low dose) will be taken by 1 day single use and 10 days multiple use. the subjects will be assigned to low dose treatment in random order

Trial Locations (1)

Unknown

1220.52.86001 Boehringer Ingelheim Investigational Site, Beijing

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY